Randomized Phase III Study of the Addition of Cisplatin in Combination With Gemcitabine as First-line Therapy for Elderly Patients With Advanced Non Small Cell Lung Cancer.
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 19 Jul 2017
At a glance
- Drugs Cisplatin (Primary) ; Gemcitabine (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- Acronyms MILES-3
- 14 Jul 2017 Planned primary completion date changed from 1 Jun 2017 to 1 Sep 2017.
- 06 Jun 2017 A joint analysis of the multicenter, randomized phase III MILES-3 and MILES-4 studies (from Mar 2011 to Aug 2016, 531 patients) presented at the 53rd Annual Meeting of the American Society of Clinical Oncology
- 15 Jan 2013 Planned End Date changed from 1 Jun 2013 to 1 Jun 2015 as reported by ClinicalTrials.gov.